Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1942-1952

  Cestari, Igor ^a,c   Ansa Addo, Ephraim ^b   Deolindo, Poliana ^a   Inal, Jameel M ^b   Ramirez, Marcel I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; CELL INVASION; CELL MEMBRANE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME STABILITY; HOST CELL; IMMUNE EVASION; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE; MEMBRANE VESICLE; MONOCYTE; MOUSE; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRYPANOSOMA CRUZI;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CHAGAS DISEASE; COMPLEMENT C3-C5 CONVERTASES; CYTOPLASMIC VESICLES; ERYTHROCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MONOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI;

EID: 84856887544     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102053     Document Type: Article

References (58)

1. Buscaglia, C. A., V. A. Campo, A. C. Frasch, and J. M. Di Noia. 2006. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 4: 229-236.
2. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
3. Yoshida, N., and M. F. Araguth. 1987. Trypanolytic activity and antibodies to metacyclic trypomastigotes of Trypanosoma cruzi in non-Chagasic human sera. Parasite Immunol. 9: 389-393. (Pubitemid 17074204)
4. Almeida, I. C., S. R. Milani, P. A. Gorin, and L. R. Travassos. 1991. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J. Immunol. 146: 2394-2400.
5. Krettli, A. U., P. Weisz-Carrington, and R. S. Nussenzweig. 1979. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. Clin. Exp. Immunol. 37: 416-423. (Pubitemid 9238280)
6. Krautz, G. M., J. C. Kissinger, and A. U. Krettli. 2000. The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol. Today (Regul.Ed.) 16: 31-34.
7. Cestari, I., and M. I. Ramirez. 2010. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PLoS One 5: e9721.
8. Yoshida, N. 2006. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An. Acad. Bras. Cienc. 78: 87-111.
9. Andrews, N. W. 1995. Lysosome recruitment during host cell invasion by Trypanosoma cruzi. Trends Cell Biol. 5: 133-137.
10. Al-Nedawi, K., B. Meehan, J. Micallef, V. Lhotak, L. May, A. Guha, and J. Rak. 2008. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10: 619-624. (Pubitemid 351627382)
11. Mack, M., A. Kleinschmidt, H. Brühl, C. Klier, P. J. Nelson, J. Cihak, J. Plachý, M. Stangassinger, V. Erfle, and D. Schlöndorff. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6: 769-775. (Pubitemid 30469425)
12. Gasser, O., C. Hess, S. Miot, C. Deon, J. C. Sanchez, and J. A. Schifferli. 2003. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp. Cell Res. 285: 243-257. (Pubitemid 36432112)
13. Bebawy, M., V. Combes, E. Lee, R. Jaiswal, J. Gong, A. Bonhoure, and G. E. Grau. 2009. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23: 1643-1649.
14. Combes, V., N. Coltel, M. Alibert, M. van Eck, C. Raymond, I. Juhan-Vague, G. E. Grau, and G. Chimini. 2005. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 166: 295-302. (Pubitemid 40051681)
15. Combes, V., A. C. Simon, G. E. Grau, D. Arnoux, L. Camoin, F. Sabatier, M. Mutin, M. Sanmarco, J. Sampol, and F. Dignat-George. 1999. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104: 93-102. (Pubitemid 29534349)
16. Faille, D., V. Combes, A. J. Mitchell, A. Fontaine, I. Juhan-Vague, M. C. Alessi, G. Chimini, T. Fusaï, and G. E. Grau. 2009. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 23: 3449-3458.
17. Ansa-Addo, E. A., S. Lange, D. Stratton, S. Antwi-Baffour, I. Cestari, M. I. Ramirez, M. V. McCrossan, and J. M. Inal. 2010. Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. J. Immunol. 185: 5236-5246.
18. Pilzer, D., O. Gasser, O. Moskovich, J. A. Schifferli, and Z. Fishelson. 2005. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin. Immunopathol. 27: 375-387. (Pubitemid 41639888)
19. Cocucci, E., G. Racchetti, and J. Meldolesi. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19: 43-51.
20. Combes, V., T. E. Taylor, I. Juhan-Vague, J. L. Mege, J. Mwenechanya, M. Tembo, G. E. Grau, and M. E. Molyneux. 2004. Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA 291: 2542-2544. (Pubitemid 38702769)
21. Coltel, N., V. Combes, S. C. Wassmer, G. Chimini, and G. E. Grau. 2006. Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect. 8: 2305-2316. (Pubitemid 44322058)
22. Bridges, D. J., J. Bunn, J. A. van Mourik, G. Grau, R. J. Preston, M. Molyneux, V. Combes, J. S. O'Donnell, B. de Laat, and A. Craig. 2010. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 115: 1472-1474.
23. Cestari, I. d. S., A. Krarup, R. B. Sim, J. M. Inal, and M. I. Ramirez. 2009. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol. Immunol. 47: 426-437.
24. Contreras, V. T., J. M. Salles, N. Thomas, C. M. Morel, and S. Goldenberg. 1985. In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol. Biochem. Parasitol. 16: 315-327. (Pubitemid 16248528)
25. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450. (Pubitemid 15114340)
26. Seelen, M. A., A. Roos, J. Wieslander, T. E. Mollnes, A. G. Sjöholm, R. Wurzner, M. Loos, F. Tedesco, R. B. Sim, P. Garred, et al. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296: 187-198. (Pubitemid 40174752)
27. Cestari, I. d. S., I. Evans-Osses, J. C. Freitas, J. M. Inal, and M. I. Ramirez. 2008. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. J. Infect. Dis. 198: 1276-1283.
28. Dodds, A. W. 1993. Small-scale preparation of complement components C3 and C4. Methods Enzymol. 223: 46-61. (Pubitemid 23321179)
29. MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant. 2001. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835. (Pubitemid 34008509)
30. Zhang, Y., D. Liu, X. Chen, J. Li, L. Li, Z. Bian, F. Sun, J. Lu, Y. Yin, X. Cai, et al. 2010. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39: 133-144.
31. Kuttner-Kondo, L. A., M. P. Dybvig, L. M. Mitchell, N. Muqim, J. P. Atkinson, M. E. Medof, and D. E. Hourcade. 2003. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. J. Biol. Chem. 278: 52386-52391. (Pubitemid 38035829)
32. Ming, M., M. E. Ewen, and M. E. Pereira. 1995. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell 82: 287-296.
33. Hall, B. S., and M. A. Pereira. 2000. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect. Immun. 68: 2077-2081. (Pubitemid 30164839)
34. Woolsey, A. M., L. Sunwoo, C. A. Petersen, S. M. Brachmann, L. C. Cantley, and B. A. Burleigh. 2003. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J. Cell Sci. 116: 3611-3622. (Pubitemid 37063404)
35. Tardieux, I., M. H. Nathanson, and N. W. Andrews. 1994. Role in host cell invasion of Trypanosoma cruzi-induced cytosolic-free Ca2+ transients. J. Exp. Med. 179: 1017-1022.
36. Dasgupta, S. K., H. Abdel-Monem, P. Niravath, A. Le, R. V. Bellera, K. Langlois, S. Nagata, R. E. Rumbaut, and P. Thiagarajan. 2009. Lactadherin and clearance of platelet-derived microvesicles. Blood 113: 1332-1339.
37. Ramirez, M. I., Rde. C. Ruiz, J. E. Araya, J. F. Da Silveira, and N. Yoshida. 1993. Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect. Immun. 61: 3636-3641.
38. Caler, E. V., S. Vaena de Avalos, P. A. Haynes, N. W. Andrews, and B. A. Burleigh. 1998. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 17: 4975-4986. (Pubitemid 28408464)
39. Manque, P. M., I. Neira, V. D. Atayde, E. Cordero, A. T. Ferreira, J. F. da Silveira, M. Ramirez, and N. Yoshida. 2003. Cell adhesion and Ca2+ signaling activity in stably transfected Trypanosoma cruzi epimastigotes expressing the metacyclic stage-specific surface molecule gp82. Infect. Immun. 71: 1561-1565. (Pubitemid 36254346)
40. Redman, C. W., and I. L. Sargent. 2008. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 29 (Suppl. A): S73-S77.
41. Distler, J. H., D. S. Pisetsky, L. C. Huber, J. R. Kalden, S. Gay, and O. Distler. 2005. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 52: 3337-3348. (Pubitemid 41612200)
42. Gasser, O., and J. A. Schifferli. 2005. Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp. Cell Res. 307: 381-387. (Pubitemid 40799363)
43. Ferreira, V., C. Valck, G. Sánchez, A. Gingras, S. Tzima, M. C. Molina, R. Sim, W. Schwaeble, and A. Ferreira. 2004. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J. Immunol. 172: 3042-3050. (Pubitemid 38263693)
44. Schenkman, S., M. L. Güther, and N. Yoshida. 1986. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody. J. Immunol. 137: 1623-1628. (Pubitemid 16014816)
45. Joiner, K., A. Sher, T. Gaither, and C. Hammer. 1986. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proc. Natl. Acad. Sci. USA 83: 6593-6597. (Pubitemid 17174781)
46. Tomlinson, S., L. C. Pontes de Carvalho, F. Vandekerckhove, and V. Nussenzweig. 1994. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J. Immunol. 153: 3141-3147. (Pubitemid 24292539)
47. Schneider, M. C., B. E. Prosser, J. J. Caesar, E. Kugelberg, S. Li, Q. Zhang, S. Quoraishi, J. E. Lovett, J. E. Deane, R. B. Sim, et al. 2009. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-893.
48. Domínguez, M., I. Moreno, M. López-Trascasa, and A. Toraño. 2002. Complement interaction with trypanosomatid promastigotes in normal human serum. J. Exp. Med. 195: 451-459. (Pubitemid 34461298)
49. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41: 1089-1098. (Pubitemid 39345390)
50. Horakova, E., O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli. 2004. Complement mediates the binding of HIV to erythrocytes. J. Immunol. 173: 4236-4241. (Pubitemid 39280790)
51. Comis, A., and S. B. Easterbrook-Smith. 1986. Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine. FEBS Lett. 197: 321-327. (Pubitemid 16037943)
52. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927. (Pubitemid 43090447)
53. Valenti, R., V. Huber, P. Filipazzi, L. Pilla, G. Sovena, A. Villa, A. Corbelli, S. Fais, G. Parmiani, and L. Rivoltini. 2006. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 66: 9290-9298. (Pubitemid 44521151)
54. Araújo-Jorge, T. C., M. C. Waghabi, A. M. Hasslocher-Moreno, S. S. Xavier, Mde. L. Higuchi, M. Keramidas, S. Bailly, and J. J. Feige. 2002. Implication of transforming growth factor-beta1 in Chagas disease myocardiopathy. J. Infect. Dis. 186: 1823-1828. (Pubitemid 35463516)
55. Waghabi, M. C., M. Keramidas, S. Bailly, W. Degrave, L. Mendonça-Lima, Mde. N. Soeiro, Mde. N. Meirelles, S. Paciornik, T. C. Araújo-Jorge, and J. J. Feige. 2005. Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am. J. Pathol. 167: 993-1003. (Pubitemid 41416252)
56. Waghabi, M. C., C. M. Coutinho, M. N. Soeiro, M. C. Pereira, J. J. Feige, M. Keramidas, A. Cosson, P. Minoprio, F. Van Leuven, and T. C. Araújo-Jorge. 2002. Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin. Infect. Immun. 70: 5115-5123.
57. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J. Exp. Med. 174: 539-545.
58. Waghabi, M. C., M. Keramidas, J. J. Feige, T. C. Araujo-Jorge, and S. Bailly. 2005. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell. Microbiol. 7: 511-517. (Pubitemid 40439450)